RedHill Biopharma RDHL
NASDAQ RDHL
$0.69 +0.04 (+5.31%)
As of: Sep 9, 2026 · 3:59 PM EDT

RedHill Biopharma (RDHL) EPS (Diluted) (2012 - 2023)

Analysis

RedHill Biopharma (RDHL) EPS (Diluted) (2012 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -0.49
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -0.10
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 0.06
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 0.21
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 0.69
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -0.23
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 1.13
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 0.69
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 0.05
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.27
Mar 31, 2023 -0.17
Dec 31, 2022 -1.49
Sep 30, 2022 -0.46
Jun 30, 2022 0.14
Mar 31, 2022 0.27
Dec 31, 2021 -3.12
Sep 30, 2021 0.45
Jun 30, 2021 0.70
Mar 31, 2021 0.45
Dec 31, 2020 0.51
Sep 30, 2020 0.35
Jun 30, 2020 0.30
Mar 31, 2020 0.55
Dec 31, 2019 0.40
Sep 30, 2019 0.43
Jun 30, 2019 0.60
Mar 31, 2019 0.37
Dec 31, 2018 0.54
Sep 30, 2018 0.53